GREGORY M SULLIVAN Insider Trading $TNXP Tonix Pharmaceuticals Holding Corp.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY M SULLIVAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY M SULLIVAN. GREGORY M SULLIVAN is Chief Medical Officer in Tonix Pharmaceuticals Holding Corp. ($TNXP) and CFO and COO in New York REIT, Inc. ($NYRT).
GREGORY M SULLIVAN in Tonix Pharmaceuticals Holding Corp.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY M SULLIVAN: Chief Medical Officer
Holdings: 62,727 shares
Current Value: $33,245
Latest Transaction: Feb 25 2021
$TNXP Market Capitalization: $21.31M
$TNXP Previous Close: $0.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GREGORY M SULLIVAN in Tonix Pharmaceuticals Holding Corp.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2021 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 1.53 | 750,000 | 1,147,500 | 750,000 | |
| Feb 25 2021 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 1.22 | 750,000 | 915,000 | 750,000 | |
| Feb 25 2021 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Grant | A | 0.51 | 41,322 | 21,074 | 62,727 | 21.4 K to 62.7 K (+193.05 %) |
| Aug 19 2020 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Buy | P | 1.03 | 20,000 | 20,600 | 21,405 | 1.4 K to 21.4 K (+1,423.49 %) |
| May 06 2020 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 0.96 | 500,000 | 480,000 | 500,000 | |
| May 06 2020 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 0.77 | 500,000 | 385,000 | 500,000 | |
| May 08 2019 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 2.56 | 43,252 | 110,725 | 43,252 | |
| May 08 2019 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 2.05 | 43,253 | 88,669 | 43,253 | |
| Feb 27 2019 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 2.36 | 7,755 | 18,302 | 7,755 | |
| Feb 27 2019 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 1.89 | 7,755 | 14,657 | 7,755 | |
| Jun 15 2018 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Buy | P | 3.97 | 10,000 | 39,650 | 20,482 | 10.5 K to 20.5 K (+95.40 %) |
| Feb 15 2018 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 4.25 | 58,725 | 249,581 | 58,725 | |
| Feb 15 2018 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 3.40 | 58,726 | 199,668 | 58,726 | |
| Mar 01 2017 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 0.55 | 75,000 | 41,250 | 75,000 | |
| Mar 01 2017 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 0.55 | 75,000 | 41,250 | 75,000 | |
| Jun 03 2016 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Buy | P | 2.50 | 20,000 | 49,916 | 43,185 | 23.2 K to 43.2 K (+86.26 %) |
| Feb 10 2016 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 5.03 | 30,000 | 150,900 | 30,000 | |
| Feb 10 2016 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 5.03 | 30,000 | 150,900 | 30,000 | |
| Sep 30 2015 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Buy | P | 5.18 | 5,000 | 25,900 | 16,925 | 11.9 K to 16.9 K (+41.93 %) |
| Sep 28 2015 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Buy | P | 5.95 | 4,694 | 27,925 | 11,925 | 7.2 K to 11.9 K (+64.91 %) |
| Jun 11 2015 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Buy | P | 8.38 | 4,500 | 37,710 | 7,231 | 2.7 K to 7.2 K (+164.77 %) |
| Feb 27 2015 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 5.95 | 26,500 | 157,675 | 26,500 | |
| Nov 03 2014 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 6.68 | 26,500 | 177,020 | 26,500 | |
| Jun 20 2014 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 9.87 | 26,500 | 261,555 | 0 |
Page: 1